| ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers K Bergethon, AT Shaw, SH Ignatius Ou, R Katayama, CM Lovly, ... Journal of clinical oncology 30 (8), 863-870, 2012 | 1965 | 2012 |
| Proteomic patterns of tumour subsets in non-small-cell lung cancer K Yanagisawa, Y Shyr, BJ Xu, PP Massion, PH Larsen, BC White, ... The Lancet 362 (9382), 433-439, 2003 | 806 | 2003 |
| Significance of p63 amplification and overexpression in lung cancer development and prognosis PP Massion, PM Taflan, SM Jamshedur Rahman, P Yildiz, Y Shyr, ... Cancer research 63 (21), 7113-7121, 2003 | 423 | 2003 |
| γ-Secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers J Konishi, KS Kawaguchi, H Vo, N Haruki, A Gonzalez, DP Carbone, ... Cancer research 67 (17), 8051-8057, 2007 | 325 | 2007 |
| Dominant-negative Notch3 receptor inhibits mitogen-activated protein kinase pathway and the growth of human lung cancers N Haruki, KS Kawaguchi, S Eichenberger, PP Massion, S Olson, ... Cancer research 65 (9), 3555-3561, 2005 | 210 | 2005 |
| Early involvement of the phosphatidylinositol 3-kinase/Akt pathway in lung cancer progression PP Massion, PM Taflan, Y Shyr, SMJ Rahman, P Yildiz, B Shakthour, ... American journal of respiratory and critical care medicine 170 (10), 1088-1094, 2004 | 185 | 2004 |
| A training-testing approach to the molecular classification of resected non-small cell lung cancer N Yamagata, Y Shyr, K Yanagisawa, M Edgerton, TP Dang, A Gonzalez, ... Clinical Cancer Research 9 (13), 4695-4704, 2003 | 164 | 2003 |
| Constitutive activation of Notch3 inhibits terminal epithelial differentiation in lungs of transgenic mice TP Dang, S Eichenberger, A Gonzalez, S Olson, DP Carbone Oncogene 22 (13), 1988-1997, 2003 | 149 | 2003 |
| Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonism L Yang, Y Huang, R Porta, K Yanagisawa, A Gonzalez, E Segi, ... Cancer research 66 (19), 9665-9672, 2006 | 147 | 2006 |
| Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma ET Shinohara, A Gonzalez, PP Massion, H Chen, M Li, AS Freyer, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2005 | 141 | 2005 |
| Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer PB Yildiz, Y Shyr, JSM Rahman, NR Wardwell, LJ Zimmerman, ... Journal of Thoracic Oncology 2 (10), 893-901, 2007 | 125 | 2007 |
| Epidermal growth factor receptor (EGFR) antibody down-regulates mutant receptors and inhibits tumors expressing EGFR mutations M Perez-Torres, M Guix, A Gonzalez, CL Arteaga Journal of Biological Chemistry 281 (52), 40183-40192, 2006 | 118 | 2006 |
| Nuclear survivin as a biomarker for non-small-cell lung cancer B Lu, A Gonzalez, PP Massion, Y Shyr, B Shaktour, DP Carbone, ... British journal of cancer 91 (3), 537-540, 2004 | 114 | 2004 |
| Proteomic patterns of preinvasive bronchial lesions SM Jamshedur Rahman, Y Shyr, PB Yildiz, AL Gonzalez, H Li, X Zhang, ... American journal of respiratory and critical care medicine 172 (12), 1556-1562, 2005 | 101 | 2005 |
| Smoking induces epithelial-to-mesenchymal transition in non–small cell lung cancer through HDAC-mediated downregulation of E-cadherin NS Nagathihalli, PP Massion, AL Gonzalez, P Lu, PK Datta Molecular cancer therapeutics 11 (11), 2362-2372, 2012 | 99 | 2012 |
| In-depth proteomic analysis of nonsmall cell lung cancer to discover molecular targets and candidate biomarkers T Kikuchi, M Hassanein, JM Amann, Q Liu, RJC Slebos, SMJ Rahman, ... Molecular & Cellular Proteomics 11 (10), 916-932, 2012 | 92 | 2012 |
| Oncogenic function of a novel WD-domain protein, STRAP, in human carcinogenesis SK Halder, G Anumanthan, R Maddula, J Mann, A Chytil, AL Gonzalez, ... Cancer research 66 (12), 6156-6166, 2006 | 87 | 2006 |
| Lung cancer diagnosis from proteomic analysis of preinvasive lesions SMJ Rahman, AL Gonzalez, M Li, EH Seeley, LJ Zimmerman, XJ Zhang, ... Cancer research 71 (8), 3009-3017, 2011 | 83 | 2011 |
| Peroxisome proliferator–activated receptor β/δ expression and activation in lung cancer TV Pedchenko, AL Gonzalez, DZ Wang, RN DuBois, PP Massion American Journal of Respiratory Cell and Molecular Biology 39 (6), 689-696, 2008 | 79 | 2008 |
| Genetic and proteomic features associated with survival after treatment with erlotinib in first-line therapy of non-small cell lung cancer in Eastern Cooperative Oncology Group … JM Amann, JW Lee, H Roder, J Brahmer, A Gonzalez, JH Schiller, ... Journal of Thoracic Oncology 5 (2), 169-178, 2010 | 78 | 2010 |
